- Home
- IGT vs KRYS Comparison
IGT vs KRYS Comparison
Compare IGT & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGT
- KRYS
- Stock Information
- Founded
- IGT 2014
- KRYS 2015
- Country
- IGT United Kingdom
- KRYS United States
- Employees
- IGT N/A
- KRYS N/A
- Industry
- IGT Services-Misc. Amusement & Recreation
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IGT Consumer Discretionary
- KRYS Health Care
- Exchange
- IGT Nasdaq
- KRYS Nasdaq
- Market Cap
- IGT 3.2B
- KRYS 3.6B
- IPO Year
- IGT N/A
- KRYS 2017
- Fundamental
- Price
- IGT $14.55
- KRYS $130.91
- Analyst Decision
- IGT Strong Buy
- KRYS Strong Buy
- Analyst Count
- IGT 4
- KRYS 8
- Target Price
- IGT $23.25
- KRYS $211.13
- AVG Volume (30 Days)
- IGT 2.6M
- KRYS 432.0K
- Earning Date
- IGT 05-13-2025
- KRYS 05-06-2025
- Dividend Yield
- IGT 5.50%
- KRYS N/A
- EPS Growth
- IGT 44.55
- KRYS 109.01
- EPS
- IGT 1.62
- KRYS 4.16
- Revenue
- IGT $2,434,000,000.00
- KRYS $333,448,000.00
- Revenue This Year
- IGT $2.39
- KRYS $48.66
- Revenue Next Year
- IGT $1.52
- KRYS $49.81
- P/E Ratio
- IGT $8.96
- KRYS $31.43
- Revenue Growth
- IGT 14.38
- KRYS 247.53
- 52 Week Low
- IGT $13.81
- KRYS $122.80
- 52 Week High
- IGT $24.13
- KRYS $219.34
- Technical
- Relative Strength Index (RSI)
- IGT 35.41
- KRYS 40.45
- Support Level
- IGT $14.90
- KRYS $123.03
- Resistance Level
- IGT $15.79
- KRYS $127.59
- Average True Range (ATR)
- IGT 0.51
- KRYS 4.54
- MACD
- IGT -0.17
- KRYS 1.19
- Stochastic Oscillator
- IGT 8.90
- KRYS 62.41
About IGT International Game Technology
International Game Technology PLC is a gaming company that delivers entertaining and responsible gaming experiences for players across all channels. The company operates into single segment namely Gaming & Digital. Geographically, it derives a majority of revenue from the United States. The company also has its presence in Italy, Rest of Europe and Other countries.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.